Siranush Khaladzhyan
Nurse Practitioner · Las Vegas, NVNPI 1427780030
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 247 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 247 payments — averaging $23.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$947
- Novartis$940
- Biogen$513
- EMD Serono, Inc.$457
- UCB, Inc.$384
- Acadia Pharmaceuticals Inc$347
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,879100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $947 |
| Novartis | 45 | $940 |
| Biogen | 20 | $513 |
| EMD Serono, Inc. | 11 | $457 |
| UCB, Inc. | 16 | $384 |
| Acadia Pharmaceuticals Inc | 9 | $347 |
| Eisai Inc. | 27 | $332 |
| SK Life Science, Inc. | 8 | $323 |
| Argenx US, Inc. | 8 | $192 |
| Pfizer | 9 | $191 |
| Genentech USA, Inc. | 9 | $171 |
| Lilly USA, LLC | 9 | $159 |
| Amgen | 1 | $138 |
| Bristol Myers Squibb | 7 | $116 |
| E.r. Squibb & Sons, L.L.C. | 1 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $90 |
| Alnylam Pharmaceuticals Inc. | 3 | $89 |
| Lundbeck LLC | 3 | $86 |
| AstraZeneca | 3 | $48 |
| Scilex Pharmaceuticals Inc. | 2 | $34 |
| Merz Pharmaceuticals, LLC | 1 | $29 |
| C2n Diagnostics, LLC | 1 | $26 |
| Johnson & Johnson | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Livanova USA, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Genentech, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Inogen, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,879 in reported general payments places this provider in the 90th percentile of 933 nurse practitioner providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 16 | $190 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Las Vegas
- Melanie SpeedLas Vegas$80K
- Shelley MilesLas Vegas$34K
- Nasslynne LenzLas Vegas$32K
- Shannon SouthwickLas Vegas$32K
- Bonnie KwanLas Vegas$30K
- Amanda RalphLas Vegas$26K
- Teodoro AgtayLas Vegas$25K
- Katherine WhitmireLas Vegas$18K
- Jennifer WalshLas Vegas$18K
- Andrew VolinLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.